← Leaderboards
Philip W Shaul
University Of Texas Sw Med Ctr/Dallas
$27,032,562
Attributed
$29,905,989
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,905,989 · 18
By mechanism
R01$23,775,546 · 11
U01$2,983,343 · 1
T32$2,948,665 · 1
P51$198,435 · 5
Top collaborators
- Lance S Terada10 shared
- David Y Hui4 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Joachim J Herz$19,473,068
Others in their field
Top investigators on “Nitric Oxide Synthase”
- Solomon H Snyder · Johns Hopkins University$21,917,530
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$18,412,089
- Jay Louis Zweier · Ohio State University$18,105,943
- Dennis J Stuehr · Cleveland Clinic Foundation$17,503,802
- Costantino Iadecola · Weill Medical Coll Of Cornell Univ$16,413,413
- Jonathan S. Stamler · Case Western Reserve University$15,214,291
Research focus
Nitric Oxide SynthaseBlood VesselsMediatingProgramsEndothelial CellsEndotheliumIn VivoGene ExpressionSignal TransductionAtherosclerosisAttenuatedBaseCardiovascular DiseasesEstradiolGenesApolipoprotein ELigandsNovel TherapeuticsLungEstrogen ReceptorsCardiovascular SystemPreventProteinsCell Culture Techniques
Grant awards (81)
Endothelial Cell SR-BI Regulation and Novel Protein Partners in Atherosclerosis$772,275
R01 · FY2025 · HL · contact PI
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE$1
T32 · FY2024 · HL
Unraveling ApoE4 Promotion of Cardiometabolic Disease$570,405
R01 · FY2023 · HL · contact PI
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE$198,711
T32 · FY2023 · HL
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease$586,193
R01 · FY2022 · HL · contact PI
Unraveling ApoE4 Promotion of Cardiometabolic Disease$570,405
R01 · FY2022 · HL · contact PI
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE$330,093
T32 · FY2022 · HL
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease$586,193
R01 · FY2021 · HL · contact PI
Unraveling ApoE4 Promotion of Cardiometabolic Disease$568,956
R01 · FY2021 · HL · contact PI
Unraveling ApoE4 Promotion of Cardiometabolic Disease$348,665
R01 · FY2021 · HL · contact PI
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE$259,496
T32 · FY2021 · HL
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease$586,194
R01 · FY2020 · HL · contact PI
Unraveling ApoE4 Promotion of Cardiometabolic Disease$568,376
R01 · FY2020 · HL · contact PI
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE$509,678
T32 · FY2020 · HL
Dichotomous Role of Endothelial SR-BI in Atherosclerosis$405,000
R01 · FY2020 · HL · contact PI
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease$601,693
R01 · FY2019 · HL · contact PI
Dichotomous Role of Endothelial SR-BI in Atherosclerosis$405,000
R01 · FY2019 · HL · contact PI
Dichotomous Role of Endothelial SR-BI in Atherosclerosis$405,000
R01 · FY2018 · HL · contact PI
Training Program in Lung Biology and Disease$182,983
T32 · FY2018 · HL
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$698,117
R01 · FY2017 · HL
Dichotomous Role of Endothelial SR-BI in Atherosclerosis$405,000
R01 · FY2017 · HL · contact PI
Training Program in Lung Biology and Disease$365,890
T32 · FY2017 · HL
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$698,117
R01 · FY2016 · HL
Fc gamma RIIB and Inflammation-Related Vascular Disease$357,750
R01 · FY2016 · HL · contact PI
Training Program in Lung Biology and Disease$308,892
T32 · FY2016 · HL
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$688,102
R01 · FY2015 · HL
Training Program in Lung Biology and Disease$445,258
T32 · FY2015 · HL
Fc gamma RIIB and Inflammation-Related Vascular Disease$352,383
R01 · FY2015 · HL · contact PI
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$713,853
R01 · FY2014 · HL
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease$384,442
R01 · FY2014 · HL · contact PI
Fc gamma RIIB and Inflammation-Related Vascular Disease$350,595
R01 · FY2014 · HL · contact PI
Training Program in Lung Biology and Disease$347,663
T32 · FY2014 · HL
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease$373,458
R01 · FY2013 · HL · contact PI
Fc gamma RIIB and Inflammation-Related Vascular Disease$356,262
R01 · FY2013 · HL · contact PI
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease$392,288
R01 · FY2012 · HL · contact PI
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease$396,250
R01 · FY2011 · HL · contact PI
CRP, eNOS and Endothelial Dysfunction$543,710
R01 · FY2010 · HL · contact PI
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease$396,250
R01 · FY2010 · HL · contact PI
Estrogen Modulation of Endothelial Cell Phenotype$238,497
R01 · FY2010 · HD · contact PI
CRP, eNOS and Endothelial Dysfunction$543,710
R01 · FY2009 · HL · contact PI
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease$381,118
R01 · FY2009 · HL · contact PI
Estrogen Modulation of Endothelial Cell Phenotype$240,906
R01 · FY2009 · HD · contact PI
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease$381,118
R01 · FY2008 · HL · contact PI
Estrogen Modulation of Endothelial Cell Phenotype$240,906
R01 · FY2008 · HD · contact PI
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$22,649
P51 · FY2008 · RR · contact PI
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease$381,118
R01 · FY2007 · HL · contact PI
Cholesterol and Endothelial NO Synthase$332,812
R01 · FY2007 · HL · contact PI
CRP, eNOS and Endothelial Dysfunction$332,812
R01 · FY2007 · HL · contact PI
Estrogen Modulation of Endothelial Cell Phenotype$245,821
R01 · FY2007 · HD · contact PI
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$60,028
P51 · FY2007 · RR · contact PI
Nitric Oxide in Lung Development and CLD$540,011
U01 · FY2006 · HL · contact PI
Oxysterols, Estrogen, Receptors Anatgonism and Vascular Disease$392,500
R01 · FY2006 · HL · contact PI
CRP, eNOS and Endothelial Dysfunction$342,752
R01 · FY2006 · HL · contact PI
Cholesterol and Endothelial NO Synthase$342,752
R01 · FY2006 · HL · contact PI
Estrogen Modulation of Endothelial Cell Phenotype$253,163
R01 · FY2006 · HD · contact PI
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$59,259
P51 · FY2006 · RR · contact PI
Nitric Oxide in Lung Development and CLD$542,620
U01 · FY2005 · HL
CRP, eNOS and Endothelial Dysfunction$351,000
R01 · FY2005 · HL
Cholesterol and Endothelial NO Synthase$351,000
R01 · FY2005 · HL
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$315,900
R01 · FY2005 · HD
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$47,790
P51 · FY2005 · RR
Nitric Oxide in Lung Development and CLD$532,540
U01 · FY2004 · HL
CRP, eNOS and Endothelial Dysfunction$375,771
R01 · FY2004 · HL
Cholesterol and Endothelial NO Synthase$351,000
R01 · FY2004 · HL
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$315,900
R01 · FY2004 · HD
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$5,516
P51 · FY2004 · RR
Nitric Oxide in Lung Development and CLD$550,750
U01 · FY2003 · HL
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$339,611
R01 · FY2003 · HD
REGULATION OF CYCLOOXGENASE GENES IN DEVELOPING LUNG$303,701
R01 · FY2003 · HL
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPULMONARY DYSPLASIA$3,193
P51 · FY2003 · RR
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$339,890
R01 · FY2002 · HD
REGULATION OF CYCLOOXGENASE GENES IN DEVELOPING LUNG$296,877
R01 · FY2002 · HL
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPU$274,657
U01 · FY2002 · HL
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$339,206
R01 · FY2001 · HD
REGULATION OF CYCLOOXGENASE GENES IN DEVELOPING LUNG$290,257
R01 · FY2001 · HL
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPU$283,214
U01 · FY2001 · HL
CHOLESTEROL AND ENDOTHELIAL NO SYNTHASE TRAFFICKING$278,115
R01 · FY2001 · HL
REGULATION OF CYCLOOXGENASE GENES IN DEVELOPING LUNG$282,816
R01 · FY2000 · HL
CHOLESTEROL AND ENDOTHELIAL NO SYNTHASE TRAFFICKING$272,028
R01 · FY2000 · HL
NITRIC OXIDE SYNTHASES IN LUNG DEVELOPMENT AND BRONCHOPU$259,551
U01 · FY2000 · HL
REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNG$241,557
R01 · FY2000 · HD